SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.870
-0.060 (-1.53%)
At close: Jun 23, 2026, 4:00 PM EDT
3.830
-0.040 (-1.03%)
After-hours: Jun 23, 2026, 7:25 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $295.92 million as of June 23, 2026. Its market cap has increased by 1,659.52% in one year.
Market Cap
295.92M
Enterprise Value
194.70M
1-Year Change
1,659.52%
Ranking
Category
Stock Price
$3.87
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $295.92M, an increase of 126.31%. That is a compound annual growth rate of 16.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 295.92M | 66.20% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 320.80M |
| Inhibikase Therapeutics | 318.69M |
| Lineage Cell Therapeutics | 316.61M |
| Cartesian Therapeutics | 307.04M |
| MacroGenics | 307.01M |
| Conexeu Sciences | 300.71M |
| Nautilus Biotechnology | 298.64M |
| Immuneering | 293.73M |